GENEVA, April 14 -- OTSUKA PHARMACEUTICAL CO., LTD. (2-9, Kanda Tsukasa-machi, Chiyoda-ku, Tokyo1018535) filed a patent application (PCT/JP2025/080051) for "INDAZOL DERIVATIVES USEFUL FOR TREATING CANCER" on Mar 31, 2025. With publication no. WO/2026/075274, the details related to the patent application was published on Apr 09, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TAMANINI Emiliano (c/o Astex Therapeutics Limited436 Cambridge Science Park, Milton RoadCambridge, CB4 0QA), BERDINI Valerio (c/o Astex Therapeutics Limited436 Cambridge Science Park, Milton RoadCambridge, CB4 0QA), SCH&...